If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Some 20 travel staff at the FDA, who made arrangements for the regulator’s inspectors, will be getting their jobs back, as ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

FRIDAY, May 2, 2025 (HealthDay News) — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. plans to change how ...

COVID-19 booster is here, and public health officials are urging seniors and immunocompromised people to get protected ahead ...

Too easily overlooked are non-influenza, non-COVID viruses and bacteria that are burgeoning and spreading unchecked — both in ...

Streptococcus Group A affects close to 20% of U.S. children, according to Dr. Joshua Osowicki, senior research fellow at the ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

The market expects ANI Pharmaceuticals (ANIP) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus ...

Health Secretary Robert F. Kennedy Jr. on Thursday announced plans to require all new vaccines to be tested against placebos ...